CymaBay Therapeutics, Inc.
Why Is CymaBay Therapeutics, Inc. (CBAY) Stock Up Today?
Live update on CBAY's stock movement with key data on price change, volume, technical indicators, sector trends, and analyst sentiment.
Summary
CymaBay Therapeutics, Inc. (CBAY) is trading up +0.03% at $32.48, reflecting a positive shift in investor sentiment today. The stock opened at $32.49 and has moved between $32.48 and $32.50 so far.
Trading volume is 8354629, which is 112% above its average, and the price action suggests buying interest.
Technically, CBAY is trading above its 50-day moving average of $28.59 and above its 200-day moving average of $18.42, indicating short-term and long-term strength.
Meyka's AI assigns CBAY a grade of B (Overall moderate), reflecting its assessment of fundamentals and sentiment. Forecast models project potential returns of +102.24% in 1 year ($65.69), and +125.81% in 5 years ($73.34).
In context, the broader Healthcare sector is down -2.56% today, which may be contributing to the move.
View the full chart, check forecasting details, or see the AI grade breakdown to explore what's driving this stock's movement.
Stay informed and make better investment decisions.
CBAY Technical Signals
Trading over 50-day moving average ($28.59)
Trading over 200-day moving average ($18.42)
Sector Context
The Healthcare sector is down -2.56% today, with the Biotechnology industry contributing to the decline. This broader context may be weighing on the stock's performance.
Price Forecast
1 Month
N/A
1 Year
$65.69
3 Years
$73.59
5 Years
$73.34
Is this change significant?
5-Day:N/A
1-Month:+0.03%
3-Month:+32.57%
What's next?
Next earnings date: 7/30/2025